117 related articles for article (PubMed ID: 2514580)
41. Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps.
Meyskens FL; Emerson SS; Pelot D; Meshkinpour H; Shassetz LR; Einspahr J; Alberts DS; Gerner EW
J Natl Cancer Inst; 1994 Aug; 86(15):1122-30. PubMed ID: 8028034
[TBL] [Abstract][Full Text] [Related]
42. In vivo effects of 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A) and alpha-difluoromethylornithine (DFMO) on L1210 growth, cell-cycle phase distribution and polyamine contents.
Dorhout B; te Velde RJ; Ferwerda H; Kingma AW; de Hoog E; Muskiet FA
Int J Cancer; 1995 Sep; 62(6):738-42. PubMed ID: 7558423
[TBL] [Abstract][Full Text] [Related]
43. Polyamines as biomarkers of cervical intraepithelial neoplasia.
Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
[TBL] [Abstract][Full Text] [Related]
44. Luminal polyamines substitute for tissue polyamines in duodenal mucosal repair after stress in rats.
Wang JY; Johnson LR
Gastroenterology; 1992 Apr; 102(4 Pt 1):1109-17. PubMed ID: 1551519
[TBL] [Abstract][Full Text] [Related]
45. Experience affects cortical but not subcortical polyamines.
Ferchmin PA; Eterović VA
Pharmacol Biochem Behav; 1990 Jan; 35(1):255-8. PubMed ID: 2107554
[TBL] [Abstract][Full Text] [Related]
46. [Low-molecular-weight regulators of biogenic polyamine metabolism affect cytokine production and expression of hepatitis С virus proteins in Huh7.5 human hepatocarcinoma cells].
Masalova OV; Lesnova EI; Samokhvalov EI; Permyakova KY; Ivanov AV; Kochetkov SN; Kushch AA
Mol Biol (Mosk); 2017; 51(3):512-523. PubMed ID: 28707668
[TBL] [Abstract][Full Text] [Related]
47. Effects of DFMO-induced polyamine depletion on human tumor cell sensitivity to antineoplastic DNA-crosslinking drugs.
Seidenfeld J; Komar KA; Naujokas MF; Block AL
Cancer Chemother Pharmacol; 1986; 17(1):16-20. PubMed ID: 3084110
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of deoxyribonucleic acid synthesis by difluoromethylornithine. Role of polyamine metabolism in monocrotaline-induced pulmonary hypertension.
Hacker AD
Biochem Pharmacol; 1992 Sep; 44(5):965-71. PubMed ID: 1530663
[TBL] [Abstract][Full Text] [Related]
49. Effect of ornithine in parenteral nutrition regimens on difluoromethylornithine-induced platelet suppression and changes in tumor polyamine content.
Grossie VB; Nishioka K
Cancer Invest; 1998; 16(3):160-5. PubMed ID: 9541629
[TBL] [Abstract][Full Text] [Related]
50. 2-Deoxy-D-glucose inhibits the antitumor effects of alpha-difluoromethylornithine on the growth of colon cancer in vivo.
Saydjari R; Upp JR; Alexander RW; Barranco SC; Townsend CM; Thompson JC
Invest New Drugs; 1989 Jul; 7(2-3):131-8. PubMed ID: 2507471
[TBL] [Abstract][Full Text] [Related]
51. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
[TBL] [Abstract][Full Text] [Related]
52. Stress-induced dynamic changes in mouse brain polyamines. Role in behavioral reactivity.
Gilad GM; Gilad VH
Brain Res; 2002 Jul; 943(1):23-9. PubMed ID: 12088835
[TBL] [Abstract][Full Text] [Related]
53. Eflornithine treatment in SHR: potential role of vascular polyamines and ornithine decarboxylase in hypertension.
Soltis EE; Newman PS; Olson JW
Clin Exp Hypertens; 1994 Sep; 16(5):595-610. PubMed ID: 7951165
[TBL] [Abstract][Full Text] [Related]
54. Polyamine regulation of plasma membrane phospholipid flip-flop during apoptosis.
Bratton DL; Fadok VA; Richter DA; Kailey JM; Frasch SC; Nakamura T; Henson PM
J Biol Chem; 1999 Oct; 274(40):28113-20. PubMed ID: 10497162
[TBL] [Abstract][Full Text] [Related]
55. Depletion of polyamines prevents the neurotrophic activity of the GABA-agonist THIP in cultured rat cerebellar granule cells.
Abraham JH; Hansen GH; Seiler N; Schousboe A
Neurochem Res; 1993 Feb; 18(2):153-8. PubMed ID: 8474558
[TBL] [Abstract][Full Text] [Related]
56. Microbial flora in the gastrointestinal tract abolishes cytostatic effects of alpha-difluoromethylornithine in vivo.
Hessels J; Kingma AW; Ferwerda H; Keij J; van den Berg GA; Muskiet FA
Int J Cancer; 1989 Jun; 43(6):1155-64. PubMed ID: 2525116
[TBL] [Abstract][Full Text] [Related]
57. Effect of treatment with difluoromethylornithine on polyamine and spectrin breakdown levels in neonatal rat brain.
Najm I; Vanderklish P; Lynch G; Baudry M
Brain Res Dev Brain Res; 1991 Nov; 63(1-2):287-9. PubMed ID: 1790596
[TBL] [Abstract][Full Text] [Related]
58. [Effect of alpha-difluoromethylornithine and polyhexamethyleneguanidine (PMG), polyamine biosynthesis inhibitors on leucosis L1210 growth kinetics and life expectancy of animals with cancer].
Zaletok SP; Berdinskikh NK; Lialiushko NM; Klenov OA; Samoĭlenko EA; Lidak MIu
Lik Sprava; 2005 Dec; (8):76-81. PubMed ID: 16498791
[TBL] [Abstract][Full Text] [Related]
59. The additive effect of alpha-difluoromethylornithine (DFMO) and radiation therapy on a rat glioma model.
Tsukahara T; Tamura M; Yamazaki H; Kurihara H; Matsuzaki S
J Cancer Res Clin Oncol; 1992; 118(3):171-5. PubMed ID: 1548280
[TBL] [Abstract][Full Text] [Related]
60. Mononuclear cell polyamine content associated with myeloid maturation in patients with leukemia during administration of polyamine inhibitors.
Maddox AM; Keating MJ; Freireich EJ; Haddox MK
Invest New Drugs; 1989 Jul; 7(2-3):119-29. PubMed ID: 2507470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
